- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2025. Philstar Global Corp. All Rights Reserved
X

+ Follow ACUTE MYOCARDIAL INFARCTION TRIAL Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 237722 [Title] => Results of landmark heart study bared [Summary] => More than 2,000 heart specialists and other practicing physicians gathered at the Le Pavillion in Manila last Jan. 22 to listen to the presentation of the results and clinical implications of a landmark study that researchers hope will change the medical landscape in the management of heart diseases.
Results of VALIANT (Valsartan in Acute Myocardial Infarction Trial) was presented to doctors from all over the country by Prof. Inder Anand, chief of the Cardiology Section of the Veterans Affair Medical Center in Minneapolis, USA.
[DatePublished] => 2004-02-05 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 236012 [Title] => Landmark trial shows benefits of ‘valsartan’ [Summary] => Internationally respected medical authorities reported at the American Heart Association meeting held recently in Orlando, Florida that valsartan, a drug for high blood pressure belonging to the angiotensin II receptor blocker (ARB) family, is as effective as the ACE-inhibitor captopril in reducing the risk of death and other non-fatal cardiovascular events (CV) among high-risk patients, as results of the VALIANT study show.
[DatePublished] => 2004-01-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [2] => Array ( [ArticleID] => 228628 [Title] => Landmark study presented in US gab [Summary] => More than 25,000 heart specialists and researchers gathered at the Orange County Convention Center in Orlando, Florida recently for the 76th annual scientific sessions of the American Heart Association (AHA) to discuss new developments in the management of cardiovascular diseases.
Researchers said a new clinical study provides evidence that treatment of heart attack patients with the angiotensin receptor blocker valsartan is as effective as the proven dose of the angiotensin-converting enzyme (ACE) inhibitor captopril.
[DatePublished] => 2003-11-20 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
ACUTE MYOCARDIAL INFARCTION TRIAL
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 237722 [Title] => Results of landmark heart study bared [Summary] => More than 2,000 heart specialists and other practicing physicians gathered at the Le Pavillion in Manila last Jan. 22 to listen to the presentation of the results and clinical implications of a landmark study that researchers hope will change the medical landscape in the management of heart diseases.
Results of VALIANT (Valsartan in Acute Myocardial Infarction Trial) was presented to doctors from all over the country by Prof. Inder Anand, chief of the Cardiology Section of the Veterans Affair Medical Center in Minneapolis, USA.
[DatePublished] => 2004-02-05 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 236012 [Title] => Landmark trial shows benefits of ‘valsartan’ [Summary] => Internationally respected medical authorities reported at the American Heart Association meeting held recently in Orlando, Florida that valsartan, a drug for high blood pressure belonging to the angiotensin II receptor blocker (ARB) family, is as effective as the ACE-inhibitor captopril in reducing the risk of death and other non-fatal cardiovascular events (CV) among high-risk patients, as results of the VALIANT study show.
[DatePublished] => 2004-01-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [2] => Array ( [ArticleID] => 228628 [Title] => Landmark study presented in US gab [Summary] => More than 25,000 heart specialists and researchers gathered at the Orange County Convention Center in Orlando, Florida recently for the 76th annual scientific sessions of the American Heart Association (AHA) to discuss new developments in the management of cardiovascular diseases.
Researchers said a new clinical study provides evidence that treatment of heart attack patients with the angiotensin receptor blocker valsartan is as effective as the proven dose of the angiotensin-converting enzyme (ACE) inhibitor captopril.
[DatePublished] => 2003-11-20 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
February 5, 2004 - 12:00am
January 22, 2004 - 12:00am
November 20, 2003 - 12:00am
Relevant. Witty. Daily
Morning news briefings from Philstar.com
or sign in with
Recommended
Vice President Sara Duterte has asked the Department of Justice to junk the inciting to sedition and grave threats complaints filed against her by the National Bureau of Investigation, in connection with her alleged assassination threat against President Marcos and some of his family members.
14 hours ago
The government will raise procedural issues, particularly the sub judice rule, in response to the complaint filed by Sen. Imee Marcos with the Office of the Ombudsman against officials over the arrest and turnover of former president Rodrigo Duterte to the International Criminal Court, Justice Secretary Jesus Crispin Remulla said yesterday.
14 hours ago
In her last pitch for the senatorial candidates endorsed by her family, Vice President Sara Duterte took a swipe against President Marcos and candidates whom she accused of forming an “alliance” that she said would sink the country deeper into poverty.
14 hours ago
The Philippines votes Monday in a ballot that will decide half the Senate's seats, thousands of local posts, and quite possibly the political future of impeached Vice President Sara Duterte.
22 hours ago
Vice President Sara Duterte again claimed widespread fraud has been planned for next week's midterm elections, saying at PDP Laban's miting de avance Thursday night that cheating may have already begun in "the election of alyansa."
1 day ago
Lotto May 9, 2025
6/58 Ultra Lotto
54434041436
JACKPOT PRIZE: 49,500,000.00 PHP
6/45 Lotto
33453973026
JACKPOT PRIZE: 40,541,906.00 PHP
6D Lotto
4247
SUERTRES
792
EZ2/LVM
304
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66